Ads
related to: novartis pharmaceuticals newsscbn.org has been visited by 10K+ users in the past month
Search results
The Zacks Analyst Blog Highlights Procter & Gamble, Novartis, Mondelez International, Elevance...
Zacks via Yahoo Finance· 6 months agoFor Immediate Release Chicago, IL – November 21, 2023 – Zacks.com announces the list of stocks...
Novartis sees brighter sales future as R&D revamp continues
BioPharma Dive via Yahoo Finance· 6 months agoDive Brief: Novartis expects sales to grow faster than anticipated over the next five years as...
Novartis raises forecasts as top drug sales beat Wall Street estimates
BioPharma Dive via Yahoo Finance· 3 weeks agoSales of Novartis drugs for heart failure, psoriasis and multiple sclerosis were stronger over the...
The Zacks Analyst Blog Highlights Regeneron Pharmaceuticals, Merck, Novartis and AstraZeneca
Zacks via Yahoo Finance· 9 months agoFor Immediate Release Chicago, IL – August 29, 2023 – Zacks.com announces the list of stocks...
Novartis bet on kidney disease drug yields positive study data
BioPharma Dive via Yahoo Finance· 7 months agoDive Brief: An experimental kidney disease drug Novartis acquired via a $3 billion deal earlier this...
Novartis gets FDA approval of closely watched rare disease drug
BioPharma Dive via Yahoo Finance· 5 months agoDive Brief: The Food and Drug Administration has approved a new Novartis drug for adults with a rare...
Novartis to buy Mariana Oncology in radiopharmaceutical expansion
BioPharma Dive via Yahoo Finance· 2 weeks agoDive Brief: Novartis is expanding its pipeline of radiopharmaceutical drugs, announcing Thursday it...
Novartis leans toward spinoff of generic drugs unit - Bloomberg News
Reuters via Yahoo News· 2 years agoA challenging macro environment for leveraged buyouts has made the sale route difficult and Novartis...
Could This Biosimilar Drug Candidate Be a Hit for Novartis?
Motley Fool· 2 years agoOn Sept. 19, Novartis (NYSE: NVS) shared positive news with investors regarding the clinical trial...
Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market
Investor's Business Daily· 3 weeks agoNovartis blazed a trail for treating cancer with targeted radiopharmaceuticals, a treatment that...